ADAMTS5 and metabolic dysfunction-associated steatohepatitis: Previous studies comparing Adamts5-/--P [13] and WT mice kept on HFD revealed: (i) reduced WAT mass, (ii) increased BAT mass, (iii) enhanced browning of WAT, (iv) enhanced insulin sensitivity, and (v) protection against NASH for KO mice [11, 12, 14].